Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Carter

Showing results (1601-1610 of 1,799) with videos related to

Pageof 180
Sort By:
Oncogene|March 4, 2021
A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastomaBelamy B Cheung, Ane Kleynhans, Rituparna Mittra, et al.
Journal of Medicinal Chemistry|April 13, 2022
Development of <b>VU6019650</b>: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M<sub>5</sub> Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use DisorderAaron T Garrison, Douglas L Orsi, Rory A Capstick, et al.
International Journal of Epidemiology|November 22, 2020
Metabolic profiles of socio-economic position: a multi-cohort analysisOliver Robinson, Alice R Carter, Mika Ala-Korpela, et al.
Neuron|August 12, 2020
Plasticity and Spontaneous Activity Pulses in Disused Human Brain CircuitsDillan J Newbold, Timothy O Laumann, Catherine R Hoyt, et al.
Acta Orthopaedica|April 2, 2015
A proposed set of metrics for standardized outcome reporting in the management of low back painR Carter Clement, Adina Welander, Caleb Stowell, et al.
International Journal of Cancer|November 8, 2022
Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastomaJanith A Seneviratne, Daniel R Carter, Rituparna Mittra, et al.
Nature Communications|July 7, 2021
Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemiaQuentin Van Thillo, Jolien De Bie, Janith A Seneviratne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2015
Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted TreatmentIrina Lambertz, Candy Kumps, Shana Claeys, et al.
Communications Biology|October 14, 2024
Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesisBelamy B Cheung, Ritu Mittra, Jayne Murray, et al.
Cancer Research|September 11, 2019
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding InterfaceJessica Koach, Jessica K Holien, Hassina Massudi, et al.
Pageof 180

Showing results (1601-1610 of 1,799) with videos related to

Sort By:
Pageof 180
Oncogene|March 4, 2021
A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastomaBelamy B Cheung, Ane Kleynhans, Rituparna Mittra, et al.
Journal of Medicinal Chemistry|April 13, 2022
Development of <b>VU6019650</b>: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M<sub>5</sub> Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use DisorderAaron T Garrison, Douglas L Orsi, Rory A Capstick, et al.
International Journal of Epidemiology|November 22, 2020
Metabolic profiles of socio-economic position: a multi-cohort analysisOliver Robinson, Alice R Carter, Mika Ala-Korpela, et al.
Neuron|August 12, 2020
Plasticity and Spontaneous Activity Pulses in Disused Human Brain CircuitsDillan J Newbold, Timothy O Laumann, Catherine R Hoyt, et al.
Acta Orthopaedica|April 2, 2015
A proposed set of metrics for standardized outcome reporting in the management of low back painR Carter Clement, Adina Welander, Caleb Stowell, et al.
International Journal of Cancer|November 8, 2022
Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastomaJanith A Seneviratne, Daniel R Carter, Rituparna Mittra, et al.
Nature Communications|July 7, 2021
Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemiaQuentin Van Thillo, Jolien De Bie, Janith A Seneviratne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2015
Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted TreatmentIrina Lambertz, Candy Kumps, Shana Claeys, et al.
Communications Biology|October 14, 2024
Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesisBelamy B Cheung, Ritu Mittra, Jayne Murray, et al.
Cancer Research|September 11, 2019
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding InterfaceJessica Koach, Jessica K Holien, Hassina Massudi, et al.
Pageof 180